Franklin Resources’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-5,341
| Closed | -$14.4K | – | 2396 |
|
2022
Q4 | $14.4K | Hold |
5,341
| – | – | ﹤0.01% | 2287 |
|
2022
Q3 | $21K | Hold |
5,341
| – | – | ﹤0.01% | 2251 |
|
2022
Q2 | $37K | Sell |
5,341
-2,581
| -33% | -$17.9K | ﹤0.01% | 2272 |
|
2022
Q1 | $93K | Hold |
7,922
| – | – | ﹤0.01% | 2307 |
|
2021
Q4 | $145K | Sell |
7,922
-98,813
| -93% | -$1.81M | ﹤0.01% | 2288 |
|
2021
Q3 | $2.67M | Buy |
106,735
+1,131
| +1% | +$28.3K | ﹤0.01% | 1377 |
|
2021
Q2 | $6.67M | Buy |
105,604
+11,756
| +13% | +$743K | ﹤0.01% | 1075 |
|
2021
Q1 | $11.6M | Hold |
93,848
| – | – | ﹤0.01% | 945 |
|
2020
Q4 | $10.7M | Buy |
93,848
+4
| +0% | +$455 | ﹤0.01% | 946 |
|
2020
Q3 | $11.2M | Hold |
93,844
| – | – | 0.01% | 879 |
|
2020
Q2 | $11.7M | Buy |
+93,844
| New | +$11.7M | 0.01% | 834 |
|
2018
Q2 | – | Sell |
-2,778
| Closed | -$7.52M | – | 1540 |
|
2018
Q1 | $7.52M | Buy |
+2,778
| New | +$7.52M | ﹤0.01% | 977 |
|